This is the story of a young science-writer at Memorial Sloan-Kettering Cancer Center, who risked everything by blowing the whistle on a massive cover-up involving a promising cancer Laetrile therapy.
The launch of the War On Cancer in the early 1970s set the stage for massive influx of new ideas in fighting cancer. Memorial Sloan-Kettering Cancer Center, America's leading cancer research center at the time, was assigned the task of testing one of the most "quackish" of all "quack remedies" in an effort to curb the public's "false hope" in the alleged therapy.
Ralph Moss, PhD, a young and eager science writer, was hired by Sloan-Kettering's public relations department in 1974, to help brief the American public on the center's contribution to the War On Cancer. Shortly after starting his position, Moss befriended one of the center's oldest and leading research scientists, Dr. Kanematsu Sugiura—an original co-founder of chemotherapy.
While meeting with this iconic scientist to pen a biography on his extensive 60-year career at Sloan-Kettering, Moss discovered that Sugiura had been studying this "quack remedy" in laboratory mice for nearly 2 years, and with unexpectedly positive results. Shocked and bewildered, Moss reported back to his superiors what he had discovered, only to be met with backlash and denial from Sloan-Kettering's leaders on what their own leading scientist had found.
Fueled by respect and admiration for Sugiura, Ralph Moss spent over four years in his attempts to publicize the truth about Sugiura's findings. And after all diplomatic approaches failed, Moss lived a double life working as a loyal employee at Sloan-Kettering while also recruiting his fellow employees to help anonymously leak this information to the American people through a newly formed underground organization they called—"Second Opinion".
“Though a documentary, it’s dramatic enough to be reminiscent of ‘The Insider,’ the whistleblowing thriller about Big Tobacco.” —Graham Fuller, New York Daily News, 9/28/14 Second Opinion: Laetrile At Sloan-Kettering - Trailer
The Treacherous Cancer Organized Crime Syndicate is Too Prosperous to Allow a Cure.
The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. This film shows us the enduring fight of a man who was brave enough to stand up for his convictions and what he knew to be the truth, risking it all to inform the public of a sham perpetrated by organizations that remain open today largely due to the support of the public that they've lied to.
The Documents http://www.secondopinionfilm.com/the-documents/
